NCT04074967: An ongoing trial by Dan Zandberg
This trial is ongoing. It must report results 1 week, 4 days from now.
Full data
| Full entry on ClinicalTrials.gov | NCT04074967 |
|---|---|
| Title | A Phase Ib/II Study of ARRY-614 Plus Either Nivolumab or Nivolumab+Ipilimumab in Advanced Solid Tumors |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | June 11, 2020 |
| Completion date | Dec. 27, 2024 |
| Required reporting date | Dec. 27, 2025, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |